Decreased expression of MPL on the cell surface of platelets, megakaryocytes, and CD34+ cells is an established feature of polycythemia vera and myelofibrosis [28–30]. JAK2V617F directly downmodulates MPL [31]. Here, MPL is linked to acquired polycythemia vera.